CD4 and ovarian carcinoma: In conclusion, our study found that the increased IL‐6 and TNF‐α levels in recurrent ovarian cancer patients, while the decreased IFN‐γ level, the CD4+ T‐cell proportion, and the CD4+/CD8+ ratio.